What happened
The World Economic Forum's Centre for Health and Healthcare, in collaboration with LSE Health, published this white paper on June 29, 2026. It argues that 'global investment in healthcare AI exceeded $18 billion in 2025, yet health systems still lack a shared understanding of the outcomes that investment should deliver.' The paper's central concept is 'value inversion' — a structural misalignment where 'AI's value is defined disproportionately by those furthest from its consequences,' meaning procurement decisions are driven by efficiency metrics convenient to administrators rather than outcomes meaningful to patients and frontline clinicians. Drawing on expert interviews with health system leaders, technology developers, and policymakers, it proposes four governance principles: identify outcomes bottom-up through patient and clinician engagement; co-create definitions through public–private collaboration; prioritise outcomes over technological sophistication; and design context-sensitive frameworks for both resource-scarce and resource-abundant settings.
Why it matters
For health system executives and digital health investors, the 'value inversion' framework provides a practical governance corrective to the dominant AI procurement logic — and a defensible board-level rationale for slowing deployment until outcome metrics are defined.
Action needed
Apply the four governance principles to any active healthcare AI procurement or deployment programme; specifically, audit whether outcome metrics are defined by patients and clinicians or by the technology governance layer.